Hydration on a GLP-1

Where each label puts the fluid warning

All nine US labels use the same heading for this risk, acute kidney injury due to volume depletion, and describe the same pattern: reports of sudden kidney injury after the body lost fluid, usually through stomach and bowel side effects ^{[1][2][3][4][5][6][7][8][9]}. What differs is the section number and how the patient-facing text puts it. The table is a reading aid; the leaflet in your own pack is what applies to you.

From an upset stomach to a kidney problem

The chain the labels describe has three links. Stomach and bowel effects are the most frequent reactions to these medicines: in the two main Zepbound® weight trials, 56% of people on tirzepatide reported one, against 30% on placebo ^[7]. Vomiting and diarrhea take water and salts out of the body. And nausea makes drinking harder, which MedlinePlus lists among the everyday reasons people end up short of fluid ^[14].

The labels say most kidney injury reports came from exactly this setting, and they ask prescribers to watch kidney function most closely at the start of treatment and after each dose increase ^[2][7]. The Wegovy® label adds that kidney problems in its weight trials were more frequent in people who already had impaired kidney function and during dose escalation ^[2]. The Canadian Zepbound® monograph notes that, across GLP-1 receptor agonists, some reported cases involved people with no known kidney disease ^[12]. Our article on the kidney warning goes through the case reports and trial numbers in more depth.

Low blood pressure and fainting

Losing fluid can also pull blood pressure down. In the Wegovy® weight trials, reactions related to low blood pressure were counted in 1.3% of adults on semaglutide against 0.4% on placebo, and fainting in 0.8% against 0.2%; some followed stomach reactions and volume loss, and low blood pressure was seen more often in people already on blood pressure treatment ^[2].

The Zepbound® label reports low blood pressure in 1.6% on tirzepatide and 0.1% on placebo, again more often alongside blood pressure medicines and at times together with stomach reactions and dehydration ^[7]. MedlinePlus lists diuretics, often called water pills, among the medicines that make you pass more urine ^[14]. If you take one, lightheadedness on standing is worth raising with your prescriber.

Do these medicines change thirst?

GLP-1 receptor agonists reduce appetite, and a research group in Basel asked whether they also reduce drinking. In a randomised crossover trial, 20 healthy volunteers spent three weeks on weekly dulaglutide and three weeks on placebo. On dulaglutide all but four drank less during an eight-hour test visit, though the difference fell just short of statistical significance; urine output over 24 hours was lower, and thirst ratings did not change ^[16].

A second trial by the same group, in 34 people with primary polydipsia, a condition of excessive drinking, found lower fluid intake and lower thirst perception on dulaglutide than on placebo ^[17]. Both trials were short and small, and both used dulaglutide, the active ingredient of Trulicity®. They hint that thirst may be blunted, but they did not measure dehydration and say nothing direct about other medicines or about everyday users. They are a reason to pay attention, not a basis for any target.

Signs that you are running low

• Early signs on the MedlinePlus list: thirst, a dry or sticky mouth, passing little urine or darker yellow urine, dry and cool skin, headache and muscle cramps ^[14].
• Signs of severe dehydration: no urine or very dark, amber urine, dizziness or lightheadedness, a racing heart or fast breathing, confusion or irritability, sunken eyes, and dry, shrivelled skin ^[14].
• Who is more exposed: older adults and people with diabetes, according to MedlinePlus ^[14]; the European Mounjaro® information singles out older people too ^[11].
• Feeling too unwell to drink is itself on the MedlinePlus list of causes, next to heavy sweating, fever and passing a lot of urine ^[14].

What the sources suggest doing

None of the documents turns this into a schedule or a volume. What they do say is brief:

• Drink fluids to lower the chance of dehydration, as the Medication Guides put it ^[1][2][4]. The European Mounjaro® leaflet and the Canadian Zepbound® patient information speak of drinking plenty of fluids to prevent it ^[11][12].
• With a fever, vomiting or diarrhea, MedlinePlus says to keep drinking rather than wait for signs of dehydration, and to call your provider early if you think someone may become dehydrated ^[14].
• When you feel sick, MedlinePlus suggests small amounts of clear liquids, often ^[15]. For mild dehydration it mentions sipping water, sucking on ice cubes or drinks that contain electrolytes, and it warns against salt tablets ^[14].
• The Dietary Guidelines for Americans, 2025–2030 point to water, still or sparkling, and unsweetened drinks, and describe sodium and electrolytes as part of hydration ^[13].
• Before starting semaglutide, MedlinePlus asks you to tell your doctor about recent vomiting, diarrhea or nausea, or trouble drinking liquids by mouth ^[10].

Why there is no daily number

The labels are written around a risk rather than a routine: they say when fluid matters and leave the amount to the people treating you. The Dietary Guidelines speak to the general population and do not set a figure for people on these medicines either ^[13]. A number you see online may be a general rule of thumb, but it does not come from the prescribing information.

What you need depends on your kidney function, your other medicines, the weather, how active you are and whether you are losing fluid through vomiting or diarrhea ^[2][14]. If you have kidney disease or take a diuretic, ask your prescriber whether any particular caution applies to you.

Ozempic®, Wegovy®, Rybelsus®, Saxenda® and Victoza® are registered trademarks of Novo Nordisk A/S. Mounjaro®, Zepbound® and Trulicity® are registered trademarks and Foundayo™ is a trademark of Eli Lilly and Company. PepLabo is not affiliated with or endorsed by Novo Nordisk or Eli Lilly and Company.

When to get help